Aastrom Biosciences, Inc. (ASTM) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Rock Investments Rock Investments 01/09/2014 1 Year $4.17 $3.50 -16.07% -16 Active
Comments: ixmyelocel-T in dialated cardiomyopathy (DCM)
itssofluffyimgonnadie itssofluffyimgonnadie 01/07/2014 3 months $3.81 $4.10 +7.61% 7 Ended
Comments: This stock is undervalued
bpatel bpatel 10/17/2013 3 months $4.37 $3.77 -13.73% -13 Ended
Comments:
KJames KJames 09/20/2013 3 months $0.30 $3.29 +997.4% 997 Ended
Comments:
stoplose stoplose 05/15/2013 1 Year $0.60 $3.95 +558.33% -558 Ended
Comments: this company is strong distressed
withmight withmight 05/15/2013 1 Year $0.60 $3.95 +558.33% -558 Ended
Comments: This stock is overvalued
marcelo aniloel zampolli marcelo aniloel zampolli 05/13/2013 3 months $0.60 $2.06 +245.35% 245 Ended
Comments:
university university 05/13/2013 1 Year $0.60 $3.99 +565% -565 Ended
Comments: Company is so much small and has too many competitors
everytrend everytrend 05/10/2013 1 Year $0.56 $3.80 +578.57% -578 Ended
Comments: Just had a poor earnings report
changetarget changetarget 05/10/2013 1 Year $0.56 $3.80 +578.57% -578 Ended
Comments: Just had a poor earnings report
foollnever foollnever 05/09/2013 1 Year $0.59 $3.99 +576.27% -576 Ended
Comments: Company has too many competitors
nodummy nodummy 05/09/2013 1 Year $0.59 $3.99 +576.27% -576 Ended
Comments: company is too much small than competitors
whatchoose whatchoose 05/08/2013 1 Year $0.58 $4.12 +616.27% -616 Ended
Comments: This stock is overvalued
moderate moderate 05/08/2013 1 Year $0.56 $4.12 +632.84% -632 Ended
Comments: Company should improve its management
outgetting outgetting 05/07/2013 1 Year $0.57 $4.27 +654.42% -654 Ended
Comments: Projecting declines beyond the short-term
splitsoon splitsoon 05/07/2013 1 Year $0.57 $4.27 +654.42% -654 Ended
Comments: this Company is very weak, it has got weak products
smaller smaller 05/06/2013 1 Year $0.57 $4.51 +694.01% -694 Ended
Comments: Upcoming every product launch won't be successful
luca21 luca21 05/06/2013 1 Year $0.57 $4.51 +694.01% -694 Ended
Comments: Projecting declines beyond the short-term
freak freak 05/06/2013 1 Year $0.57 $4.51 +694.01% -694 Ended
Comments: Company has too many important competitors
claimforwe claimforwe 05/06/2013 1 Year $0.57 $4.51 +694.01% -694 Ended
Comments: This stock is overvalued
Displaying 1-20 of 31
<< first < previous 1 2 last >>

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.